EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudie

Clinical Profile and Predictors of Repeated Relapse in Type 1 Autoimmune Pancreatitis: A Multicenter Observational Study

Sho Saeki, Yasutaka Ishii iD, Keiji Hanada, Tamito Sasaki, Yoshifumi Fujimoto, Atsushi Yamaguchi iD, Ken Hirao, Bunjiro Noma, Tomoyuki Minami, Akihito Okazaki, Masanobu Yukutake, Teruo Mouri und 5 weitere

Journal of Gastroenterology and Hepatology · 2025

DOI: 10.1111/jgh.70125 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of Gastroenterology and Hepatology, 2025. Verfasst von Sho Saeki und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Graduate School of Biomedical & Health Sciences, Hiroshima University, Hiroshima, Japan. Hauptthemen laut MEDLINE: Autoimmune Pancreatitis. Die Arbeit nennt 29 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aim Type 1 autoimmune pancreatitis (AIP) is a form of pancreatitis that responds well to glucocorticoid therapy and often results in clinical and radiological remission. However, AIP frequently relapses during long‐term follow‐up. While initial relapse is well described, repeated relapses are poorly understood. This study aimed to clarify their clinical features and predictors.

Methods

We retrospectively analyzed 270 patients diagnosed with type 1 AIP between 2004 and 2022 across 12 institutions. Clinical characteristics were compared among the non‐relapse, single‐relapse, and multiple‐relapse groups. Predictors of a second relapse were assessed in patients who experienced at least one relapse using Kaplan–Meier and Cox regression analyses.

Results

During a median follow‐up of 65 months, 107 patients (40%) experienced at least one relapse, and 32 (12%) had multiple relapses. The median time to second relapse was 49 months, and the cumulative second relapse rate reached 47.4% at 7 years. Multivariable analysis identified extra‐pancreatic sclerosing cholangitis at first relapse as an independent predictor of a second relapse (hazard ratio, 2.773; 95% confidence interval, 1.294–5.941; p = 0.009). Furthermore, 61% of patients whose first relapse involved the extra‐pancreatic bile duct experienced multiple relapses, often at the same site, and 73% of them were still on glucocorticoid therapy at the second relapse.

Conclusions

Second and subsequent relapses are common in type 1 AIP, and are particularly likely when the first relapse involves extra‐pancreatic sclerosing cholangitis. These patients may require more intensive monitoring and treatment beyond glucocorticoid monotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Autoimmune PancreatitisHumansMaleRecurrenceFemaleMiddle AgedRetrospective StudiesAdultAgedFollow-Up StudiesGlucocorticoidsTime FactorsRisk Factors

Stichwörter der Autor:innen

autoimmune pancreatitisglucocorticoid therapyrelapse predictionrepeated relapsesclerosing cholangitis

Substanzen

Glucocorticoids

Autor:innen und Institutionen

  • Department of Gastroenterology, Graduate School of Biomedical & Health Sciences, Hiroshima University, Hiroshima, Japan.
  • Department of Gastroenterology, National Hospital Organization Higashihiroshima Medical Center, Higashihiroshima, Japan.
  • Department of Gastroenterology, Onomichi General Hospital, Onomichi, Japan.
  • Department of Gastroenterology, Hiroshima Prefectural Hospital, Hiroshima, Japan.
  • Department of Gastroenterology, Hiroshima General Hospital, Hatsukaichi, Japan.
  • Department of Gastroenterology, Saiseikai Hiroshima Hospital, Hiroshima, Japan.

ORCID-Profile: Yasutaka Ishii, Atsushi Yamaguchi, Shiro Oka

Zitieren

APA

Saeki, S., Ishii, Y., Hanada, K., Sasaki, T., Fujimoto, Y., Yamaguchi, A., Hirao, K., Noma, B., Minami, T., Okazaki, A., Yukutake, M., Mouri, T., Kawamura, R., Nakamura, S., Ikemoto, J., Furukawa, M., & Oka, S. (2025). Clinical Profile and Predictors of Repeated Relapse in Type 1 Autoimmune Pancreatitis: A Multicenter Observational Study. Journal of Gastroenterology and Hepatology. https://doi.org/10.1111/jgh.70125

Vancouver

Saeki S, Ishii Y, Hanada K, Sasaki T, Fujimoto Y, Yamaguchi A, et al. Clinical Profile and Predictors of Repeated Relapse in Type 1 Autoimmune Pancreatitis: A Multicenter Observational Study. Journal of Gastroenterology and Hepatology. 2025. doi:10.1111/jgh.70125

BibTeX
@article{Saeki2025,
  author = {Saeki, Sho and Ishii, Yasutaka and Hanada, Keiji and Sasaki, Tamito and Fujimoto, Yoshifumi and Yamaguchi, Atsushi and Hirao, Ken and Noma, Bunjiro and Minami, Tomoyuki and Okazaki, Akihito and Yukutake, Masanobu and Mouri, Teruo and Kawamura, Ryota and Nakamura, Shinya and Ikemoto, Juri and Furukawa, Masaru and Oka, Shiro},
  title = {Clinical Profile and Predictors of Repeated Relapse in Type 1 Autoimmune Pancreatitis: A Multicenter Observational Study},
  journal = {Journal of Gastroenterology and Hepatology},
  year = {2025},
  doi = {10.1111/jgh.70125}
}
Kostenlos starten →